Adverse drug reactions (ADRs) are expected to be associated with an economic drain on the healthcare systems. The study was carried out to determine the occurrence of ADRs reported to NAFDAC Pharmacovigilance from January to June 2015, to illustrate the pattern of organ system affected by ADRs, to assess the complete- 
| INTRODUCTION
The repeated occurrence of unexpected, serious adverse drug reactions (ADRs) over the years has attracted wide professional and public attention. This has cast doubt on the effectiveness and quality of drug safety surveillance systems. 1 Adverse drug reactions (ADRs) represent an important risk for patients as they could cause significant disability and mortality, and are expected to be associated with an economic drain on the healthcare systems. 2 Adverse drug reaction signals are reported information on possible causal relationships between an adverse event and a drug. 3 A group of scientists proposed that the assessment of ADRs, therefore, is likely to be the most important aspect of drug treatment. 4 ADRs are, in fact, responsible for around 4.9% of hospital admissions worldwide, and, in some cases, this number can be as high as 41 .3%. 5 There is thus no doubt that drug safety is an important public health problem.
Spontaneous reporting of suspected adverse drug reactions has long been the cornerstone of pharmacovigilance for the identification of early signals of problems of drug safety related to the use of medicines worldwide. 6 Health professionals have contributed significantly to successful pharmacovigilance through spontaneous reporting. This enormously significant contribution has encouraged ongoing ascertainment of the benefit-risk ratio of some drugs 7, 8 , as well as contributed to signal detection of unsuspected and unusual
ADRs previously undetected during the initial evaluation of a drug. 9, 10 Pharmacovigilance is an important and integral part of clinical research. 11 It continues to play a crucial role in meeting the challenges posed by the ever increasing range and potency of medicines as it is a well-known fact that no drug is completely free from adverse effects.
In Nigeria, the National Pharmacovigilance Centre (NPC) is domicile in National Agency for Food and Drugs Administration and Control (NAFDAC) and has the data bank of all reported adverse drug reactions in Nigeria. 3 There are a bunch of examples of drugs, which have been detached as well as outlawed from the Nigerian market owing to reported adverse effects of drugs. 12 Spontaneous reporting of ADRs to the NPC in Nigeria has prompted the timely withdrawal of toxic paracetamol adulterated with diethylene glycol that claimed the lives of some infants and young children in 2008. 13, 14 
| Data abstraction
The ICSR of patients who experienced adverse drug reaction(s) from January 2015 to June 2015 were sourced from the NPC in Nigeria (NAFDAC) and data mining was done to obtain the following information: Demographic distribution of patients, batch and NAFDAC number identification for suspect drugs with ADRs, suspect drugs with ADRs (dosage form, specific indication for use, specific name, specific manufacturer), and ADR (specific type, duration, system organ classification, and outcome), reporter of ADR (institution and profession).
| ADR outcome rating
Outcome of the ADR refers to the extent of resolution of the signs and symptoms of ADR as at the time the report was submitted to NPC. The outcomes were categorized as resolved, ongoing, resolving, life-threatening, resolved with disability, and death.
| Ethical considerations
The National Agency for Food and Drug Administration and Control (NAFDAC) approved the study. 
| Specific indication for using the suspected drug(s)
The profile of specific indication for using the suspected drugs (Table 2) reveal that HIV (56.9%) was the most prevalent indication reported for using the suspected drug, followed by fever/malaria (6.9%), tuberculosis (5.7%), prevention of one ailment or the other (3.1%), etc. 'Others' represent a classification of indications only reported once.
| Suspected drugs causing ADRs
The profile of suspected drugs with ADRs (Table 3) showed that zidovudine/lamivudine/nevirapine (16.9%) combination was reported 
| Reported ADRs with suspected drugs
It was observed from the study ( Table 4 ) that the most prevalent ADR was "generalized body itching" being reported 65 times (6.9%),
"rash all over the body" was reported 49 times (5.3%), and "anemia"
was reported 35 times (3.8%). "Others" category was reserved for
ADRs with frequencies less than four. Table 5 shows a detailed list of system organ classification for the reported ADRs. Findings from the study revealed that, "general disorders" was the most predominant organ system affected by ADRs, being reported 431 times (47.3%). "Skin and subcutaneous skin disorders" was reported 238 times (26.1%). "Vascular disorders" was least reported being reported only twice (0.2%).
| Organ system classification of reported ADRs

| Source of suspected drug and nature of outcome of ADRs reported
The findings of the study revealed that most of the suspected drugs reported were sourced from the Hospital Pharmacy (Table 6) 
| Profession of reporter of ADRs
The findings in this study showed that Pharmacists (Table 7) reported ADRs the most. The "others" category refer to the pharmacy focal person, pharmacovigilance officer, human resource practitioner, media organization, house wife, self-employed person, hematolgist, engineer, teacher, as well as medical social work officer which each reported once. Dizziness is the most common specific ADR reported for artemether/lumefantrine, while treatment failure was reported twice.
| Dosage form of suspected drug with ADRs
Papilla rash is the most reported specific ADR for artemether/piperaquine. No serious ADR was documented for all the ACTs reported that is all the ADRs reported resolved without sequelae.
| DISCUSSION
The biological differences of males and females can affect the action of many drugs. The anatomical and physiological differences are body weight, body composition, gastrointestinal tract factors, liver metabolism, and renal function. Women in comparison to men have lower bodyweight and organ size, more body fat, different gastric motility and lower glomerular filtration rate. These differences can affect the way the body deals with drugs by altering the pharmacokinetics and pharmacodynamics of the drugs including drug absorption, distribution, metabolism and elimination. 18 The findings revealed that females (65.5%) were reported to have more ADRs. This is in line with several other studies which have suggested that a female preponderance in the overall frequency of adverse drug reactions may be present, in that female patients have more
ADRs. [19] [20] [21] Gender may influence drug utilization and susceptibility to, presentation of, and detection of adverse drug reactions, although the results of this study showed that the influence is not statistically significant (P > 0.05). The lack of association may be due to a large proportion of reports from females that were neither pregnant nor breastfeeding as pregnancy is a known risk factor for ADRs occurrence. 18, 22 Age has a significant effect on development of ADRs, especially the extreme ages that is pediatric and geriatric patients as these categories of patients are not usually studied extensively during clinical trials. 4 The findings in this study are however not in tandem with the aforementioned. The study revealed age range of 21-40 (45.6%) as T A B L E 1 0 Adverse drug reactions reported with artemesinin-based combination therapy (ACT) 37 There has not yet been any research into why this has occurred although speculation might pin point increased workload and administration or a presumption that others are reporting as possible reasons for this decline.
"General disorders" was the organ system (51.1%) reported to be most affected by ADRs, this is followed by skin and subcutaneous skin disorders (24.9%) and gastrointestinal disorders (7.6%).
This result is consistent with documented studies carried out in Sweden, which states that ADRs were most frequently gastrointestinal (21.6%) or general disorders (12.3%).
38
It is worth mentioning that most of the reports submitted to NAFDAC Pharmacovigilance were incomplete as they lacked necessary information like date the ADR started/stopped, suspected drug used along other requirements to validate the form. Of the 935
reported ADRs from January to June, only 509 had reported outcomes and 66.8% of the reported ADRs resolved. These findings are consistent with the previous studies reporting incompleteness of ADR forms submitted to pharmacovigilance centers in Mexico 39 and Saudi Arabia, 40 and those submitted to a pharmaceutical company in Italy. 41 Incomplete ADR information may limit the effective- 
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